DV
Dividend Vision

RYTM — Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. (RYTM)

Total return is 284.9% over the past 8.9 years, 35.9 points ahead of SPY at 249.0%. Its deepest 1-year drawdown was 35.5%.

RYTM is a single-stock equity holding in Rhythm Pharmaceuticals, a healthcare company. As a stock rather than a diversified fund, it does not distribute dividends and carries no fund-level expense ratio. This holding appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those pursuing income through dividend distributions.

RYTM key facts

Asset type
Stock
Asset class
Equity
Inception date
10/05/2017
Distribution frequency
None
Last close
$115.48
Market cap
$7,921,186,304
Average volume
334900.0
Beta
1.974
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.12